This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Schneider C, Taylor D, Zalsman G, Frangou S, Kyriakopoulos M. Antipsychotics use in children and adolescents: An on-going challenge in clinical practice. J Psychopharmacol. 2014;28(7):615-23.SchneiderCTaylorDZalsmanGFrangouSKyriakopoulosMAntipsychotics use in children and adolescents: An on-going challenge in clinical practice20142876152310.1177/026988111453359924902872Search in Google Scholar
Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharmacol. 2012;32(3):309-16.CohenDBonnotOBodeauNConsoliALaurentCAdverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis20123233091610.1097/JCP.0b013e318254925922544019Search in Google Scholar
Pappagallo M, Silva R. The effect of atypical antipsychotic agents on prolactin levels in children and adolescents. J Child Adolesc Psychopharmacol. 2004;14(3):359-71.PappagalloMSilvaRThe effect of atypical antipsychotic agents on prolactin levels in children and adolescents20041433597110.1089/cap.2004.14.35915650493Search in Google Scholar
Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Chaimani A, et al. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. Eur Neuropsychopharmacol. 2018;28(6):659-74.KrauseMZhuYHuhnMSchneider-ThomaJBighelliIChaimaniAet alEfficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis20182866597410.1016/j.euroneuro.2018.03.00829802039Search in Google Scholar
Agapoff JRt, Olson DJ, White S, Huynh V. Rapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone. J Clin Psychopharmacol. 2020;40(4):410-2.AgapoffJRtOlsonDJWhiteSHuynhVRapid and Sustained Resolution of Risperidone Associated Hyperprolactinemia and Galactorrhea With Low-Dose Lurasidone2020404410210.1097/JCP.000000000000123032555004Search in Google Scholar
Montejo AL, Arango C, Bernardo M, Carrasco JL, Crespo-Facorro B, Cruz JJ, et al. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. Front Neuroendocrinol. 2017;45:25-34.MontejoALArangoCBernardoMCarrascoJLCrespo-FacorroBCruzJJet alMultidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics201745253410.1016/j.yfrne.2017.02.00328235557Search in Google Scholar